| 17:00 | Cohort comparative analysis of antimetabolites and biologic drugs on retinal and choroidal features in Birdshot chorioretinopathy | | DE SIMONE L, CECCARELLI F, VICENTINI M, BONVICINI L, FERRARO V, BOLLETTA E, GOZZI F, GENTILE P, CIMINO L |
| 17:07 | Clinical outcomes in acute Vogt-Koyanagi-Harada patients during a 24-month follow-up | | SILVEIRA SOUTO FM, LAVEZZO M M, BRITO GONCALVES MISSAKA R F, CAMPOS DA NOBREGA P F, GUSMÃO C C, SAKATA V M, CUNNINGHAM JR E T, OYAMADA M K, HIRATA C E, YAMAMOTO J H |
| 17:14 | Sympathetic Ophthalmia: latest immunomodulatory approaches and clinical outcomes | | KITIC N, TOUTEE A, AUGER A, FARDEAU C, KITIC A, GHEMBAZA A, HIE M, SAADOUN D, BODAGHI B |
| 17:21 | Long-term follow-up of combination therapy with rituximab and mycophenolate mofetil in refractory chronic recurrent uveitis associated with Vogt-Koyanagi-Harada disease | | BOLLETTA E, BELLETTI M, GIBERTINI M, DE SIMONE L, GOZZI F, GENTILE P, CIMINO L |
| 17:28 | Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 52-Week Results from a Phase 2 Study (NEPTUNE) | | NGUYEN QD, WANG R, DACEY M, THOMAS A, GREWAL D, MUDD, JR. P |
| 17:35 | Etiological diagnosis of scleritis: contribution of the extra-ophthalmological clinical examination and paraclinical tests | | VASSENEIX C, SOUBRIER M, JACQUOT R, BERT A, GERFAUD-VALENTIN M, KODJIKIAN L, SEVE P |
| 17:42 | -- CANCELLED -- Use of blood biomarkers for the early identification of corticosteroid refractoriness in non-infectious uveitis | | VEGA-TAPIA F, VALENZUELA R, ELIZALDE N, FLORES I, ROJAS F, GOECKE A, CUITINO L, URZUA CA |
| 17:49 | Association of Diabetes Mellitus with Uveitis: A Real-World Data Analysis | | SALLAM A, JINDAL D, CHAUHAN MZ |
| | 17:56 | Closing Remarks | |
| | 18:00 | End of Session | |
